Phase 1 Trials Phase 1 trials for Retatrutide primarily focused on: Establishing the safety and optimal dosage range of the drug Involving small groups of healthy volunteers who received varying doses of Retatrutide to identify the most effective and safe dosage levels Monitoring for any adverse effects, which were generally mild and manageable This initial phase was pivotal in laying the groundwork for subsequent efficacy trials, including a clinical trial
Contact your primary care physician or psychiatrist immediately if you experience new nausea, vomiting, severe constipation, or mood changes
What is the difference between GLP-1 and GIP/GLP-1 receptor signaling
Essential Documentation Diagnosis confirmation: Lab results confirming type 2 diabetes diagnosis, including HbA1c levels, fasting glucose, and any other relevant tests
Prescribed together as an injectable peptide stack, they are the most commonly requested protocol in our Doral, FL medical clinic and the most frequently searched growth hormone peptide in the United States